Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
13 November 2013
E-012895-13
Question for written answer
to the Commission
Rule 117
Horst Schnellhardt (PPE)

 Subject:  Trans fatty acids in food
 Answer(s) 

The US Food and Drug Administration (FDA) wants to prohibit the use of industrially produced trans fatty acids in food as far as possible on account of potential risks to human health.

Studies and discussions of the links between cardiovascular diseases and the presence of trans fatty acids in food have also been taking place within the European Union for some time. Several years ago, the European Food Safety Authority recommended that levels of trans fatty acids in food be further reduced and the negative effects explained to consumers.

1. What research results relating to the effects of trans fatty acids on human health are available to the Commission?

2. What is the situation within the EU with regard to the presence of trans fatty acids in food and possible national regulations in this regard?

3. What measures does the Commission plan to take in respect of the use of industrially produced trans fatty acids in food in Europe?

Original language of question: DEOJ C 228, 17/07/2014
Last updated: 4 December 2013Legal notice